Advertisement

Topic: Gregg Stone

Jump to

Latest Headlines Quotes

Stopping aspirin after stent implant may safely cut risk of bleeding

Health News // 11 months ago

Stopping aspirin after stent implant may safely cut risk of bleeding

People who've survived a heart attack and have been given a stent may be better off quitting low-dose aspirin a month after the procedure, a new study finds.

Health News // 1 decade ago

Imaging may detect future heart disease

Identifying plaques before they cause heart disease may be possible using coronary imaging, a U.S. researcher says.

Health News // 1 decade ago

Improved function post heart attack sought

U.S. and Italian researchers say their tests show two treatment innovations improve heart function after a major heart attack.

Science News // 1 decade ago

Study: Drug-eluting stents more effective

A U.S. study has determined drug-eluting stents are more effective than, and equally as safe as, bare-metal stents.

Science News // 1 decade ago

Bivalirudin helps angioplasty survival

A U.S. study suggests heart attack victims administered the thrombin inhibitor bivalirudin during primary angioplasty had a lower mortality rate.

Health News // 1 decade ago

Angiomax on its own shows success

A year-long U.S. trial shows that bivalirudin -- sold as Angiomax -- can be used alone in some heart procedures that now rely on at least two drugs.

Health News // 1 decade ago

Angiomax reduces bleeding in heart cases

The anti-clotting agent bivalirudin (Angiomax) reduces the rate of serious bleeding incidents that occur when doctors are performing interventions on patients a

Health News // 1 decade ago

Drug-eluting stent beat radiation in study

Drug-eluting stents did better against radiation therapy in preventing restenosis and further artery clogging in a new study.

Science News // 1 decade ago

Study: Paclitaxel stents more effective

Researchers say stents that release the medication paclitaxel reduce the risk of an artery re-narrowing nine months following angioplasty.

Quotes

In patients with high-risk acute coronary syndromes undergoing an early invasive strategy, bivalirudin is an acceptable substitute for either unfractionated heparin or enoxaparin
Angiomax on its own shows success Mar 28, 2007

Bleeding is the most frequent adverse event when we perform percutaneous interventions, and now we see that bivalirudin is as effective as the combination of heparin and expensive glycoprotein IIb/IIIa inhibitors
Angiomax reduces bleeding in heart cases Nov 22, 2006

Bleeding is the most serious unintended consequence of antithrombotic therapy for acute coronary syndromes
Angiomax reduces bleeding in heart cases Nov 22, 2006

Identification of drug-eluting stents as the optimal therapy for bare metal restenosis should significantly reduce the need for surgery in many thousands of patients
Drug-eluting stent beat radiation in study Mar 13, 2006

The results are what everyone was hoping for. Drug-eluting stents should now be considered the standard of care for most patients with restenosis of previously implanted bare metal stents, and radiation treatment should be abandoned
Drug-eluting stent beat radiation in study Mar 13, 2006